66 related articles for article (PubMed ID: 10350253)
1. Effects of continuous localized infusion of granulocyte-macrophage colony-stimulating factor and inoculations of irradiated glioma cells on tumor regression.
Wallenfriedman MA; Conrad JA; DelaBarre L; Graupman PC; Lee G; Garwood M; Gregerson DS; Jean WC; Hall WA; Low WC
J Neurosurg; 1999 Jun; 90(6):1064-71. PubMed ID: 10350253
[TBL] [Abstract][Full Text] [Related]
2. Effects of irradiated tumor vaccine and infusion of granulocyte-macrophage colony-stimulating factor and interleukin-12 on established gliomas in rats.
Chen JC; Chen Y; Wu JM; Su YH; Tai KF; Tseng SH
Cancer Immunol Immunother; 2006 Jul; 55(7):873-83. PubMed ID: 16133106
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of an osmotic pump delivered, GM-CSF-based tumor vaccine in the treatment of upper aerodigestive squamous cell carcinoma in rats.
Djalilian HR; Caicedo E; Lessan K; Grami V; Le CT; Spellman SR; Pambuccian S; Hall WA; Low WC; Ondrey FG
Cancer Immunol Immunother; 2007 Aug; 56(8):1207-14. PubMed ID: 17219150
[TBL] [Abstract][Full Text] [Related]
4. Irradiated tumor cells adenovirally engineered to secrete granulocyte/macrophage-colony-stimulating factor establish antitumor immunity and eliminate pre-existing tumors in syngeneic mice.
Nagai E; Ogawa T; Kielian T; Ikubo A; Suzuki T
Cancer Immunol Immunother; 1998 Oct; 47(2):72-80. PubMed ID: 9769115
[TBL] [Abstract][Full Text] [Related]
5. Development of a successful antitumor therapeutic model combining in vivo dendritic cell vaccination with tumor irradiation and intratumoral GM-CSF delivery.
Driessens G; Nuttin L; Gras A; Maetens J; Mievis S; Schoore M; Velu T; Tenenbaum L; Préat V; Bruyns C
Cancer Immunol Immunother; 2011 Feb; 60(2):273-81. PubMed ID: 21076828
[TBL] [Abstract][Full Text] [Related]
6. Increase in tumor size following intratumoral injection of immunostimulatory CpG-containing oligonucleotides in a rat glioma model.
Ginzkey C; Eicker SO; Marget M; Krause J; Brecht S; Westphal M; Hugo HH; Mehdorn HM; Steinmann J; Hamel W
Cancer Immunol Immunother; 2010 Apr; 59(4):541-51. PubMed ID: 19798500
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic efficacy of antitumor dendritic cell vaccinations correlates with persistent Th1 responses, high intratumor CD8+ T cell recruitment and low relative regulatory T cell infiltration.
Driessens G; Gordower L; Nuttin L; Stordeur P; Blocklet D; Egrise D; Velu T; Bruyns C
Cancer Immunol Immunother; 2008 Dec; 57(12):1745-56. PubMed ID: 18369621
[TBL] [Abstract][Full Text] [Related]
8. Angiostatin-mediated suppression of cancer metastases by primary neoplasms engineered to produce granulocyte/macrophage colony-stimulating factor.
Dong Z; Yoneda J; Kumar R; Fidler IJ
J Exp Med; 1998 Aug; 188(4):755-63. PubMed ID: 9705957
[TBL] [Abstract][Full Text] [Related]
9. Monocyte chemoattractant protein-1 (MCP-1) gene transduction: an effective tumor vaccine strategy for non-intracranial tumors.
Manome Y; Wen PY; Hershowitz A; Tanaka T; Rollins BJ; Kufe DW; Fine HA
Cancer Immunol Immunother; 1995 Oct; 41(4):227-35. PubMed ID: 7489565
[TBL] [Abstract][Full Text] [Related]
10. Immunotherapy with bovine aortic endothelial cells in subcutaneous and intracerebral glioma models in rats: effects on survival time, tumor growth, and tumor neovascularization.
Corsini E; Gelati M; Calatozzolo C; Alessandri G; Frigerio S; De Francesco M; Poiesi C; Parati E; Croci D; Boiardi A; Salmaggi A
Cancer Immunol Immunother; 2004 Nov; 53(11):955-62. PubMed ID: 15449042
[TBL] [Abstract][Full Text] [Related]
11. Irradiated tumor cell vaccine for treatment of an established glioma. I. Successful treatment with combined radiotherapy and cellular vaccination.
Graf MR; Prins RM; Hawkins WT; Merchant RE
Cancer Immunol Immunother; 2002 Jun; 51(4):179-89. PubMed ID: 12012105
[TBL] [Abstract][Full Text] [Related]
12. The role of granulocyte macrophage colony stimulating factor (GM-CSF) in radiation-induced tumor cell migration.
Vilalta M; Brune J; Rafat M; Soto L; Graves EE
Clin Exp Metastasis; 2018 Apr; 35(4):247-254. PubMed ID: 29536224
[TBL] [Abstract][Full Text] [Related]
13. Effect of intraperitoneal administration of granulocyte/macrophage-colony-stimulating factor in rats on omental milky-spot composition and tumoricidal activity in vivo and in vitro.
Koenen HJ; Smit MJ; Simmelink MM; Schuurman B; Beelen RH; Meijer S
Cancer Immunol Immunother; 1996 Jun; 42(5):310-6. PubMed ID: 8706054
[TBL] [Abstract][Full Text] [Related]
14. Granulocyte- Macrophage Colony-Stimulating Factor Reverses Immunosuppression Acutely Following a Traumatic Brain Injury and Hemorrhage Polytrauma in a Juvenile Male Rat Model.
Sribnick EA; Warner T; Hall MW
J Neurotrauma; 2024 May; ():. PubMed ID: 38623766
[TBL] [Abstract][Full Text] [Related]
15. Irradiated tumor cell vaccine for treatment of an established glioma. II. Expansion of myeloid suppressor cells that promote tumor progression.
Prins RM; Scott GP; Merchant RE; Graf MR
Cancer Immunol Immunother; 2002 Jun; 51(4):190-9. PubMed ID: 12012106
[TBL] [Abstract][Full Text] [Related]
16. Regression of Breast Cancer Metastases Following Treatment with Irradiated SV-BR-1-GM, a GM-CSF Overexpressing Breast Cancer Cell Line: Intellectual Property and Immune Markers of Response.
Wiseman CL; Kharazi A; Sunkari VG; Galeas JL; Dozio V; Hashwah H; Macúchová E; Williams WV; Lacher MD
Recent Pat Anticancer Drug Discov; 2022; 18(2):224-240. PubMed ID: 35593340
[TBL] [Abstract][Full Text] [Related]
17. Case report: Interstitial implantation radiotherapy combined with immunotherapy and GM-CSF in oligometastatic platinum-resistant ovarian cancer.
Qin Y; Huang S; Tang J; Fan Y; Deng X; Guan P; Zhang Z; Wen Q; Li D
Front Immunol; 2023; 14():1329951. PubMed ID: 38235148
[TBL] [Abstract][Full Text] [Related]
18. Increasing radiation dose improves immunotherapy outcome and prolongation of tumor dormancy in a subgroup of mice treated for advanced intracerebral melanoma.
Smilowitz HM; Micca PL; Sasso D; Wu Q; Dyment N; Xue C; Kuo L
Cancer Immunol Immunother; 2016 Feb; 65(2):127-39. PubMed ID: 26660339
[TBL] [Abstract][Full Text] [Related]
19. First clinical results of a personalized immunotherapeutic vaccine against recurrent, incompletely resected, treatment-resistant glioblastoma multiforme (GBM) tumors, based on combined allo- and auto-immune tumor reactivity.
Schijns VE; Pretto C; Devillers L; Pierre D; Hofman FM; Chen TC; Mespouille P; Hantos P; Glorieux P; Bota DA; Stathopoulos A
Vaccine; 2015 May; 33(23):2690-6. PubMed ID: 25865468
[TBL] [Abstract][Full Text] [Related]
20. GM-CSF and IL-7 fusion cytokine engineered tumor vaccine generates long-term Th-17 memory cells and increases overall survival in aged syngeneic mouse models of glioblastoma.
Shireman JM; Gonugunta N; Zhao L; Pattnaik A; Distler E; Her S; Wang X; Das R; Galipeau J; Dey M
Aging Cell; 2023 Jul; 22(7):e13864. PubMed ID: 37165998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
